Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes

NCT00064727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: Avandia (Rosiglitazone)
DRUG: Avanclia (Rosiqlitazone)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)